Cardiac glycoside

Cardiac glycoside
Drug class
The general structure of a cardiac glycoside molecule.
Class identifiers
UseCongestive heart failure
ATC codeC01A
Biological targetNa+
/K+
-ATPase
External links
MeSHD002301
Legal status
In Wikidata

Cardiac glycosides are a class of organic compounds that increase the output force of the heart and decrease its rate of contractions by inhibiting the cellular sodium-potassium ATPase pump.[1] Their beneficial medical uses include treatments for congestive heart failure and cardiac arrhythmias; however, their relative toxicity prevents them from being widely used.[2] Most commonly found as secondary metabolites in several plants such as foxglove plants and milkweed plants, these compounds nevertheless have a diverse range of biochemical effects regarding cardiac cell function and have also been suggested for use in cancer treatment.[3]

  1. ^ Patel S (December 2016). "Plant-derived cardiac glycosides: Role in heart ailments and cancer management". Biomedicine & Pharmacotherapy. 84: 1036–1041. doi:10.1016/j.biopha.2016.10.030. PMID 27780131.
  2. ^ Ambrosy AP, Butler J, Ahmed A, Vaduganathan M, van Veldhuisen DJ, Colucci WS, Gheorghiade M (May 2014). "The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions" (PDF). Journal of the American College of Cardiology. 63 (18): 1823–1832. doi:10.1016/j.jacc.2014.01.051. PMID 24613328.
  3. ^ Riganti C, Campia I, Kopecka J, Gazzano E, Doublier S, Aldieri E, et al. (2011-01-01). "Pleiotropic effects of cardioactive glycosides". Current Medicinal Chemistry. 18 (6): 872–885. doi:10.2174/092986711794927685. PMID 21182478.

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search